Proton Pump Inhibitors
Cross-source consensus on Proton Pump Inhibitors from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Highlighted claims
- Proton pump inhibitors are commonly prescribed for gastrointestinal protection and acid-related conditions. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
- Long-term PPI use has been linked to hypochlorhydria, pneumonia, enteric infection, fractures, nutrient malabsorption, and osteoporotic fractures. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
- PPI deprescribing is recommended after at least 4 weeks of treatment for heartburn, mild-to-moderate gastro-oesophageal reflux disease, or oesophagitis if symptoms have resolved. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
- Long-term PPI use is considered appropriate only for Barrett's oesophagus, severe oesophagitis, or documented gastrointestinal bleeding history. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study